Skip to content

Cobra Biologics and Pharmaceutical Services

Cobra provides a comprehensive biologics and pharmaceuticals service offering, with multi-functional and experienced project teams nurturing customers’ DNA, Viral Vector and Microbiota products from pre-clinical through to clinical and commercial manufacture within GMP approved facilities.

DNA
Viruses
Protein
Microbiota
Fill Finish

Latest News

View all

Cognate BioServices Completes Acquisition of Cobra Biologics

With the addition of Cobra's specialized expertise in plasmid DNA, viral vectors, protein and microbiota, from development to fill-finish, Cognate is well-positioned as a global industry-leading services provider to deliver drug development and manufacturing solutions to the cell and gene immunotherapy and regenerative medicine industry around the world.

Find Out More

HQ Plasmid Slots Now Available

Our High Quality (HQ) offering adopts features of Cobra’s GMP manufacture with a 6 week delivery time.

Find Out More & Get In Touch Today

Cobra Biologics Receives the Queen’s Award for Enterprise in International Trade

The UK’s most prestigious business award granted in recognition of outstanding achievement in the export of services for gene and immunotherapy products.

Find Out More

Get In Touch

Speak to a member of our expert team and arrange to take a tour of our GMP facilities in the UK and Sweden.

Contact Us

About Cobra Biologics

Cobra Biologics is a leading international contract development and manufacturing organisation (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply.

2 GMP approved facilities
320+ products released for clinical trials
20 Countries serviced

@CobraBiologics

15 hours ago

ICYMI: Memphis biotech firm’s Cobra division helping develop COVID-19 vaccines >>> https://t.co/4XXocPRNht via @MBJMemphis

yesterday

We are proud of the work that our @CobraBiologics teams are doing in the fight against #covid19! A great article re… https://t.co/qeiGktkrdv

2 days ago

Memphis-based Cognate BioServices' European division is part of two teams developing COVID-19 vaccines. https://t.co/yU3zjkEchI

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.